HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 108 filers reported holding HERON THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.06 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,596 | -11.2% | 41,355 | 0.0% | 0.00% | – |
| Q2 2023 | $47,972 | -19.4% | 41,355 | +4.9% | 0.00% | – |
| Q1 2023 | $59,533 | -39.6% | 39,426 | 0.0% | 0.00% | – |
| Q4 2022 | $98,565 | -40.8% | 39,426 | 0.0% | 0.00% | – |
| Q3 2022 | $166,378 | +51.3% | 39,426 | 0.0% | 0.00% | – |
| Q2 2022 | $110,000 | -46.9% | 39,426 | +8.7% | 0.00% | – |
| Q1 2022 | $207,000 | -37.8% | 36,274 | -0.7% | 0.00% | -100.0% |
| Q4 2021 | $333,000 | -87.5% | 36,533 | -85.3% | 0.00% | -80.0% |
| Q3 2021 | $2,655,000 | -34.4% | 248,367 | -4.8% | 0.01% | -37.5% |
| Q2 2021 | $4,049,000 | +11.0% | 260,919 | +16.0% | 0.01% | +14.3% |
| Q1 2021 | $3,647,000 | -34.6% | 224,992 | -14.6% | 0.01% | -36.4% |
| Q4 2020 | $5,577,000 | +930.9% | 263,518 | +622.5% | 0.01% | +1000.0% |
| Q3 2020 | $541,000 | +5.5% | 36,473 | +4.5% | 0.00% | 0.0% |
| Q2 2020 | $513,000 | +3.6% | 34,894 | -17.2% | 0.00% | 0.0% |
| Q1 2020 | $495,000 | -48.7% | 42,129 | +2.6% | 0.00% | -50.0% |
| Q4 2019 | $965,000 | +80.4% | 41,077 | +42.1% | 0.00% | +100.0% |
| Q3 2019 | $535,000 | -0.4% | 28,902 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $537,000 | -22.3% | 28,902 | +2.3% | 0.00% | -50.0% |
| Q1 2019 | $691,000 | -5.7% | 28,255 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $733,000 | -14.2% | 28,255 | +4.8% | 0.00% | 0.0% |
| Q3 2018 | $854,000 | -12.0% | 26,972 | +7.9% | 0.00% | 0.0% |
| Q2 2018 | $971,000 | +59.7% | 24,993 | +13.5% | 0.00% | +100.0% |
| Q1 2018 | $608,000 | +64.8% | 22,011 | +8.0% | 0.00% | 0.0% |
| Q4 2017 | $369,000 | +12.2% | 20,377 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $329,000 | +16.7% | 20,377 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $282,000 | +33.0% | 20,377 | +44.4% | 0.00% | – |
| Q1 2017 | $212,000 | +22.5% | 14,110 | +6.8% | 0.00% | – |
| Q4 2016 | $173,000 | -24.1% | 13,211 | 0.0% | 0.00% | – |
| Q3 2016 | $228,000 | -4.2% | 13,211 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $238,000 | -5.2% | 13,211 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $251,000 | -28.9% | 13,211 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $353,000 | +9.6% | 13,211 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $322,000 | -21.8% | 13,211 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $412,000 | +64.1% | 13,211 | -23.4% | 0.00% | 0.0% |
| Q1 2015 | $251,000 | +44.3% | 17,249 | 0.0% | 0.00% | – |
| Q4 2014 | $174,000 | +20.8% | 17,249 | 0.0% | 0.00% | – |
| Q3 2014 | $144,000 | -32.4% | 17,249 | 0.0% | 0.00% | – |
| Q2 2014 | $213,000 | – | 17,249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |